Results 111 to 120 of about 62,320 (268)
ABSTRACT Aim This study explores the trends in healthcare professionals' searches for children's oral suspension of antibiotics and antibiotic prescriptions, as well as COVID‐19 diagnoses in children under 5–6 years of age. Methods In Finland, Physician's Databases serve as a medical online source for healthcare professionals.
M. Mukka +4 more
wiley +1 more source
Kazuki Takano,1,2 Daishi Shimada,1 Shota Kashiwagura,1,3 Yasuhiro Kamioka,1,3 Maya Hariu,1,2 Yuji Watanabe,1,2 Masafumi Seki1 1Division of Infectious Diseases and Infection Control, Faculty of Medicine; 2Laboratory for Clinical Microbiology; 3Division of
Takano K +6 more
doaj
Effect of Clarithromycin in Patients with Sepsis and Ventilator-Associated Pneumonia [PDF]
Background. Because clarithromycin provided beneficiary nonantibiotic effects in experimental studies, its efficacy was tested in patients with sepsis and ventilator-associated pneumonia (VAP). Methods.
Antonopoulou, Anastasia +18 more
core
Background/Aims: Bismuth-based quadruple therapy (BQT) is a treatment option for clarithromycin-resistant Helicobacter pylori (HP) infection. The aim of this study was to compare the efficacy of 7-day BQT with that of 14-day BQT as first-line treatment ...
Chul-Hyun Lim, Jung-Hwan Oh
doaj +1 more source
Different Responses to Clarithromycin in Patients with Cryptogenic Organizing Pneumonia [PDF]
Ji Hyun Oh +7 more
openalex +1 more source
ABSTRACT Globally, rivers receive a diverse range of chemicals, including metals, pesticides, persistent organic pollutants, petrochemicals, human and veterinary pharmaceuticals and personal care products. However, the extent to which these different chemical groups affect riverine invertebrate communities is not well defined.
Imogen P. Poyntz‐Wright +2 more
wiley +1 more source
Exploring the Molecular Mechanisms of Macrolide Resistance in Laboratory Mutant Helicobacter pylori
Resistance to clarithromycin, a macrolide antibiotic used in the first-line treatment of Helicobacter pylori infection, is the most important cause of treatment failure. Although most cases of clarithromycin resistance in H.
Meltem Ayaş +4 more
doaj +1 more source
ABSTRACT Nontuberculous mycobacteria (NTM) are emerging global pathogens. This study aimed to analyze the clinical features, species distribution, and drug resistance profiles of NTM infections in a northern Chinese hospital. A retrospective cohort study included 1769 patients with suspected mycobacterial infection from August 2023 to July 2025.
Kedi Wang +4 more
wiley +1 more source
Binmaeil H, Hanafiah A, Mohamed Rose I, Raja Ali RA. Infect Drug Resist. 2021;14:4129–4145. The authors have advised that Table 1 on page 4132 is incorrect.
Binmaeil H +3 more
doaj

